Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)

CompletedOBSERVATIONAL
Enrollment

641,407

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

January 25, 2023

Study Completion Date

June 19, 2023

Conditions
Virus Diseases
Interventions
OTHER

Exposed to a SARS-CoV-2 infection

The study compared humans exposed to the SARS-CoV-2 infection with a matched group of those not exposed. No Intervention was applied.

Trial Locations (1)

01307

Center for Evidence-Based Healthcare, Technische Universität Dresden, Dresden

All Listed Sponsors
collaborator

InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH

UNKNOWN

collaborator

BARMER Institut für Gesundheitssystemforschung (bifg)

UNKNOWN

collaborator

Techniker Krankenkasse

OTHER

collaborator

DAK Gesundheit

OTHER

collaborator

AOK PLUS

INDUSTRY

collaborator

IKK Classic

UNKNOWN

lead

Technische Universität Dresden

OTHER